GNAS and KRAS mutations are frequently observed in pyloric gland adenomas and gastric‐type adenocarcinomas and are considered to represent characteristic molecular alterations in G‐type NADETs [1]. The gene discussed is KRAS; the disease is pyloric gland adenoma.